Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the international society for the study of women's sexual health and the North American Menopause Society

Menopause

Volumn 21, Issue 10, 2014, Pages 1063-1068

  Portman, David J ^a   Gass, Margery L S ^b   Kingsberg, Sheryl ^c   Archer, David ^d   Bachmann, Gloria ^e   Burrows, Lara ^f   Freedman, Murray ^g   Goldstein, Andrew ^h   Goldstein, Irwin ⁱ   Heller, Debra ^j   Iglesia, Cheryl B ^k   Kagan, Risa ^l   Spadt, Susan Kellogg ^m   Krychman, Michael ⁿ   Nachtigall, Lila ^o   Nappi, Rossella E ^p   Pinkerton, Joann V ^q   Shifren, Jan ^r   Simon, James ^s   Stuenkel, Cynthia ^t  

^a Columbus Center for Women's Health Research ^*  (United States)

^b North American Menopause Society   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d The Jones Institute for Reproductive Medicine   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f SUMMA HEALTH SYSTEM   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h The Centers for Vulvovaginal Disorders   (United States)

ⁱ San Diego Sexual Medicine   (United States)

^j RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^k GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m Pelvic and Sexual Health Institute   (United States)

ⁿ Southern California Center for Sexual Health   (United States)

^o NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF PAVIA   (Italy)

^q UNIVERSITY OF VIRGINIA   (United States)

^r MASSACHUSETTS GENERAL HOSPITAL   (United States)

^s GEORGE WASHINGTON UNIVERSITY   (United States)

^t UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Atrophic vaginitis; Genitourinary syndrome of menopause; Menopause; urinary urgency; Vulvovaginal atrophy; Women's sexual health

Indexed keywords

ADULT; ATROPHY; CONSENSUS DEVELOPMENT; FEMALE; HUMAN; MEDICAL SOCIETY; MENOPAUSE; MIDDLE AGED; NOMENCLATURE; NORTH AMERICA; PATHOLOGY; POSTMENOPAUSE; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; SYNDROME; UROGENITAL TRACT DISEASE; VAGINA; VULVA; WOMEN'S HEALTH;

ADULT; ATROPHY; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MENOPAUSE; MIDDLE AGED; NORTH AMERICA; POSTMENOPAUSE; REPRODUCTIVE HEALTH; SEXUAL BEHAVIOR; SOCIETIES, MEDICAL; SYNDROME; TERMINOLOGY AS TOPIC; VAGINA; VULVA; WOMEN'S HEALTH;

EID: 84914173526     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0000000000000329     Document Type: Article

References (43)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Am J Obstet Gynecol 2002;187:116-126.
2. National Institutes of Health. Impotence. NIH Consensus Statement. 1992;10:1-37.
3. Lizza EF, Rosen RC. Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research. Int J Impot Res 1999;11:141-143.
4. Castelo-Branco C, Huezo ML, Lagarda JL. Definition and diagnosis of sexuality in the XXI century. Maturitas 2008;60:50-58.
5. The North American Menopause Society. Menopause Practice: A Clinician's Guide. 4th ed. Mayfield Heights, OH: NAMS; 2010.
6. Bachmann G. Urogenital ageing: an old problem newly recognized. Maturitas 1995;22(Suppl):S1-S5.
7. Hirshbein LD. Gender, age, and diagnosis: the rise and fall of involutional melancholia in American psychiatry, 1900-1980. Bull Hist Med 2009;83:710-745.
8. McCall-Hosenfeld JS, Jaramillo SA, Legault C, et al. Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative Observational Study. J Gen Intern Med 2008;23:2000-2009.
9. Schneidewind-Skibbe A, Hayes RD, Koochaki PE, et al. The frequency of sexual intercourse reported by women: a review of community-based studies and factors limiting their conclusions. J Sex Med 2008;5:301-335.
10. Yen SSC, Jaffe RB, eds. Reproductive Endocrinology. 2nd ed. Philadelphia, PA: W.B. Saunders Co; 1986.
11. Tan O, Bradshaw K, Carr BR. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review. Menopause 2012;19:109-117.
12. Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 2014;17:3-9.
13. MacBride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010;85:87-94.
14. Kingsberg S, Kellogg S, Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. Int J Womens Health 2010;1:105-111.
15. Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2014;21:450-458.
16. Hummelen R, Macklaim JM, Bisanz JE, et al. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS ONE 2011;6:e26602.
17. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20: 888-902.
18. Parish SJ, Nappi RE, Krychman ML, et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437-447.
19. Winneker RC, Harris HA. Progress and prospects in treating postmenopausal vaginal atrophy. Clin Pharmacol Ther 2011;89:129-132.
20. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-358.
21. Santoro N, Komi J. Prevalence and impact of vaginal symptoms among postmenopausal women. J Sex Med 2009;6:2133-2142.
22. Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA): results from an international survey. Climacteric 2012;15:36-44.
23. Ettinger B, Hait H, Reape KZ, Shu H. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 2008;15:885-889.
24. Oge T, Hassa H, Aydin Y, Yalcin OT, Colak E. The relationship between urogenital symptoms and climacteric complaints. Climacteric 2013;16: 646-652.
25. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-774.
26. Avis NE, Brockwell S, Randolph JF Jr, et al. Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women's Health Across the Nation. Menopause 2009;16:442-452.
27. Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15(4 pt 1):661-666.
28. Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V. Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause 2014;21:137-142.
29. Robinson D, Toozs-Hobson P, Cardozo L. The effect of hormones on the lower urinary tract. Menopause Int 2013;19:155-162.
30. Robinson D, Cardozo L. The pathophysiology and management of postmenopausal urogenital oestrogen deficiency. J Br Menopause Soc 2001;7:67-73.
31. Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509-522.
32. Baldassarre M, Giannone FA, Foschini MP, et al. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-alpha and -beta expression of young women. Int J Impot Res 2013;25:172-177.
33. Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257-260.
34. Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990;12:51-60.
35. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
36. Constantine GD, Bruyniks N, Princic N, et al. Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy. Curr Med Res Opin 2014;30:143-148.
37. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008:CD005131.
38. Pinkerton JV. Vaginal impact of menopause-related estrogen deficiency. OBG Management 2010;22(suppl):S2-S7.
39. Lüthje P, Hirschberg AL, Brauner A. Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas 2014;77:32-36.
40. Nazarko L. Recurrent urinary tract infection in older women: an evidencebased approach. Br J Community Nurs 2013;18:407-412.
41. Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 2013;10:1790-1799.
42. Gott M, Hinchliff S. Barriers to seeking treatment for sexual problems in primary care: a qualitative study with older people. Fam Pract 2003; 20:690-695.
43. Simon JA, Reape KZ, Wininger S, Hait H. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women. Fertil Steril 2008; 90:1132-1138.